Leifeng Chen

2.2k total citations
83 papers, 1.7k citations indexed

About

Leifeng Chen is a scholar working on Molecular Biology, Materials Chemistry and Cancer Research. According to data from OpenAlex, Leifeng Chen has authored 83 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 25 papers in Materials Chemistry and 19 papers in Cancer Research. Recurrent topics in Leifeng Chen's work include Ubiquitin and proteasome pathways (16 papers), Graphene research and applications (13 papers) and RNA modifications and cancer (13 papers). Leifeng Chen is often cited by papers focused on Ubiquitin and proteasome pathways (16 papers), Graphene research and applications (13 papers) and RNA modifications and cancer (13 papers). Leifeng Chen collaborates with scholars based in China, United States and Denmark. Leifeng Chen's co-authors include Hua Yu, Jiasong Zhong, Zhenguo Ji, Daqin Chen, Rongfa Yuan, Weitao Su, Tian Zhang, Jianghua Shao, Xiuxia Liu and Xiaogang Peng and has published in prestigious journals such as Circulation, Applied Physics Letters and Hepatology.

In The Last Decade

Leifeng Chen

78 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leifeng Chen China 24 731 666 423 294 188 83 1.7k
Xin Shang China 26 470 0.6× 877 1.3× 182 0.4× 238 0.8× 133 0.7× 99 1.9k
Zhenning Liu China 17 396 0.5× 706 1.1× 320 0.8× 68 0.2× 140 0.7× 38 1.6k
Meng Ye China 31 2.2k 3.0× 453 0.7× 1.1k 2.5× 382 1.3× 179 1.0× 81 3.4k
Mingliang Wang China 23 557 0.8× 301 0.5× 389 0.9× 81 0.3× 380 2.0× 72 1.7k
Yaqing Chen China 22 256 0.4× 475 0.7× 243 0.6× 247 0.8× 151 0.8× 97 1.6k
Kouji Iida Japan 27 274 0.4× 1.4k 2.0× 213 0.5× 400 1.4× 404 2.1× 112 2.6k
Xiaoting Zhao China 27 562 0.8× 703 1.1× 372 0.9× 167 0.6× 195 1.0× 91 1.9k
Yajuan Feng China 18 414 0.6× 172 0.3× 332 0.8× 90 0.3× 29 0.2× 61 1.2k
Chengbao Liu China 28 727 1.0× 551 0.8× 460 1.1× 225 0.8× 467 2.5× 79 2.1k

Countries citing papers authored by Leifeng Chen

Since Specialization
Citations

This map shows the geographic impact of Leifeng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leifeng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leifeng Chen more than expected).

Fields of papers citing papers by Leifeng Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leifeng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leifeng Chen. The network helps show where Leifeng Chen may publish in the future.

Co-authorship network of co-authors of Leifeng Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Leifeng Chen. A scholar is included among the top collaborators of Leifeng Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leifeng Chen. Leifeng Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Ning, et al.. (2025). Unveiling lactylation modification: A new hope for cancer treatment. Biomedicine & Pharmacotherapy. 184. 117934–117934. 6 indexed citations
2.
Chen, Leifeng, et al.. (2025). Dualistic Roles of High Mobility Group Box 1 in Cancer and Inflammation. Cancer Medicine. 14(23). e71455–e71455.
3.
Zhang, Bolin, et al.. (2025). Targeting the ROCK2/UBA52/DRP1 axis enhances ferroptosis and overcomes pemigatinib resistance in Cholangiocarcinoma. Cell Death and Disease. 16(1). 493–493. 1 indexed citations
4.
Zhang, Lin, et al.. (2024). Squalene Epoxidase: Its Regulations and Links with Cancers. International Journal of Molecular Sciences. 25(7). 3874–3874. 10 indexed citations
5.
Yan, Xiaohua, et al.. (2024). Deubiquitinase USP10 promotes osteosarcoma autophagy and progression through regulating GSK3β-ULK1 axis. Cell & Bioscience. 14(1). 111–111. 4 indexed citations
6.
Zhang, Wenming, Zheng Xu, Yunyan Du, et al.. (2024). Identification of STAM-binding protein as a target for the treatment of gemcitabine resistance pancreatic cancer in a nutrient-poor microenvironment. Cell Death and Disease. 15(9). 657–657. 2 indexed citations
7.
Luo, Chen, Yi Yu, Jinfeng Zhu, et al.. (2024). Deubiquitinase PSMD7 facilitates pancreatic cancer progression through activating Nocth1 pathway via modifying SOX2 degradation. Cell & Bioscience. 14(1). 35–35. 6 indexed citations
8.
Zhang, Shouhua, et al.. (2023). MDM2 promotes cancer cell survival through regulating the expression of HIF-1α and pVHL in retinoblastoma. Pathology & Oncology Research. 29. 1610801–1610801. 6 indexed citations
9.
Du, Yunyan, Rongfa Yuan, Wenming Zhang, et al.. (2023). SLC35F2–SYVN1–TRIM59 axis critically regulates ferroptosis of pancreatic cancer cells by inhibiting endogenous p53. Oncogene. 42(44). 3260–3273. 18 indexed citations
10.
Huang, Haijin, Xianyun Xu, Haijin Liu, et al.. (2023). Everolimus inhibits hepatoblastoma by inducing autophagy‐dependent ferroptosis. Drug Development Research. 85(1). e22140–e22140. 3 indexed citations
11.
Yang, Yuting, Yunyan Du, Hongcheng Lu, et al.. (2023). RBX1 regulates PKM alternative splicing to facilitate anaplastic thyroid carcinoma metastasis and aerobic glycolysis by destroying the SMAR1/HDAC6 complex. Cell & Bioscience. 13(1). 36–36. 8 indexed citations
12.
Li, Ting, et al.. (2022). Mechanism and Role of Endoplasmic Reticulum Stress in Osteosarcoma. Biomolecules. 12(12). 1882–1882. 10 indexed citations
15.
Xiao, Han, Chenglin Luo, Leifeng Chen, et al.. (2019). GRP78 activates the Wnt/HOXB9 pathway to promote invasion and metastasis of hepatocellular carcinoma by chaperoning LRP6. Experimental Cell Research. 383(1). 111493–111493. 33 indexed citations
16.
Luo, Chenglin, et al.. (2018). GRP78 Promotes Hepatocellular Carcinoma proliferation by increasing FAT10 expression through the NF-κB pathway. Experimental Cell Research. 365(1). 1–11. 33 indexed citations
17.
Zhou, Qiongqiong, Xiaogang Peng, Xiao Liu, et al.. (2018). FAT10 attenuates hypoxia-induced cardiomyocyte apoptosis by stabilizing caveolin-3. Journal of Molecular and Cellular Cardiology. 116. 115–124. 33 indexed citations
18.
Shao, Jun, et al.. (2017). Overexpression of eEF1A1 regulates G1-phase progression to promote HCC proliferation through the STAT1-cyclin D1 pathway. Biochemical and Biophysical Research Communications. 494(3-4). 542–549. 40 indexed citations
19.
Liu, Xiuxia, Leifeng Chen, Ge Jin, et al.. (2016). The Ubiquitin-like Protein FAT10 Stabilizes eEF1A1 Expression to Promote Tumor Proliferation in a Complex Manner. Cancer Research. 76(16). 4897–4907. 61 indexed citations
20.
Xu, Zheng, Zhengdong Hong, Ming Ma, et al.. (2016). Rock2 promotes RCC proliferation by decreasing SCARA5 expression through β-catenin/TCF4 signaling. Biochemical and Biophysical Research Communications. 480(4). 586–593. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026